top of page

Literature Monitoring

Literature Monitoring from Clinical Development to Post-Market

surveillance monitoring

Biologit specialises in providing literature monitoring services and expert consulting to meet global regulatory requirements, including those set forth by prominent authorities such as the European Medicines Agency (EMA), Food & Drug Administration (FDA), Pharmaceuticals & Medical Device Agency (PDMA), Therapeutic Goods Administration (TGA), and more. Fuelled by the validated biologit MLM-AI platform, we are a partner for:

Clinical Development

Regulatory Affairs

Medical Affairs

Signal Management and Benefit-Risk Assessments

Systematic and proactive assessment of the literature to identify novel safety signals; preparation of regulatory submissions for signal management and benefit-risk assessments for Risk Management Plans (RMP).

Signal Management and Benefit-Risk Assessments
Medical Devices and Cosmetics

Individual Case Safety Reports (ICSR) for Medicines, Medical Devices and Cosmetics

Project planning, setup and execution of literature monitoring strategies for GVP compliant individual case safety reporting (ICSR); Clinical Evaluation Reports (CERs) and IVDR Performance Evaluation Reports (PERs) for medical devices in compliance with Medical Device Regulations (MDR) and In Vitro Diagnostics Regulations (IVDR); Cosmetics safety monitoring for Cosmetics Product Safety Report (CPSR). 

Global and Local Literature Monitoring

Streamline all your monitoring needs with a single vendor, harnessing the comprehensive coverage of the biologit Database to fulfill both global and local literature requirements seamlessly. Our simplified, multi-lingual, and unified process spans across the Americas, Europe, Africa, Oceania, and Asia.

Global and Local Literature Monitoring
Aggregate Reports

Aggregate Reports

Systematic safety information literature reviews for regulatory reporting: Periodic Safety Update Reports (PSUR), Periodic Benefit-Risk Evaluation Reports (PBRER), Development Safety Update Report (DSUR), ad-hoc reports in response to safety queries from regulatory authorities.

Clinical Development

Project setup and execution of literature search meeting clinical development FDA regulatory requirements; literature search support for ICH GCP clinical development reports, i.e. Investigator Brochure - IB and Clinical Study Protocol.

Clinical Development
usa icon

~ Service Provider, USA

“Innovative, easy to work with, good support”

ireland icon

~ Pharma, Ireland

“Professional, User-friendly, and supportive”

Get in Touch

Contact us to find out how we can help with your literature monitoring needs.

get in touch
bottom of page